Related Experiment Video
Updated: Feb 5, 2026
Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
Published on: December 17, 2019
An RNA toolbox for cancer immunotherapy
Fernando Pastor1, Pedro Berraondo2, Iñaki Etxeberria2
1Molecular Therapeutics Program, Center for Applied Medical Research, CIMA and IDISNA, Pamplona, Spain.
Abstract:
Cancer immunotherapy has revolutionized oncology practice. However, current protein and cell therapy tools used in cancer immunotherapy are far from perfect, and there is room for improvement regarding their efficacy and safety. RNA-based structures have diverse functions, ranging from gene expression and gene regulation to pro-inflammatory effects and the ability to specifically bind different molecules. These functions make them versatile tools that may advance cancer vaccines and immunomodulation, surpassing existing approaches. These technologies should not be considered as competitors of current immunotherapies but as partners in synergistic combinations and as a clear opportunity to reach more efficient and personalized results. RNA and RNA derivatives can be exploited therapeutically as a platform to encode protein sequences, provide innate pro-inflammatory signals to the immune system (such as those denoting viral infection), control the expression of other RNAs (including key immunosuppressive factors) post-transcriptionally and conform structural scaffoldings binding proteins that control immune cells by modifying their function. Nascent RNA immunotherapeutics include RNA vaccines encoding cancer neoantigens, mRNAs encoding immunomodulatory factors, viral RNA analogues, interference RNAs and protein-binding RNA aptamers. These approaches are already in early clinical development with promising safety and efficacy results.
Insights
RNA therapeutics offer a promising avenue to enhance cancer immunotherapy by improving efficacy and safety. These versatile RNA-based tools can be combined with existing treatments for more personalized and effective cancer vaccines and immunomodulation strategies.
Area of Science:
- Oncology
- Immunology
- Biotechnology
Background:
- Cancer immunotherapy has significantly advanced cancer treatment.
- Current protein and cell-based immunotherapies have limitations in efficacy and safety.
- RNA molecules possess diverse biological functions with therapeutic potential.
Purpose of the Study:
- To explore the potential of RNA-based structures as advanced tools for cancer immunotherapy.
- To highlight RNA therapeutics as complementary partners to existing treatments for improved outcomes.
- To discuss the development of novel RNA-based immunotherapeutic strategies.
Main Methods:
- Therapeutic exploitation of RNA for encoding proteins, providing immune signals, regulating gene expression, and modulating immune cells.
- Development of RNA vaccines encoding cancer neoantigens.
- Utilizing messenger RNAs (mRNAs) for immunomodulatory factors.
- Application of viral RNA analogues and interference RNAs.
- Employing RNA aptamers for protein binding and immune cell control.
Main Results:
- RNA-based therapeutics demonstrate versatility in various therapeutic applications.
- Early clinical development of nascent RNA immunotherapeutics shows promising safety and efficacy.
- RNA technologies offer potential for synergistic combinations with current immunotherapies.
Conclusions:
- RNA therapeutics represent a significant opportunity to advance cancer vaccines and immunomodulation.
- These approaches can lead to more efficient and personalized cancer treatment strategies.
- RNA-based platforms can overcome limitations of current immunotherapies, enhancing patient outcomes.
Related Concept Videos
01:27Tumor Immunotherapy
01:23RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:23RNA Structure
The basic structure of RNA consists of a five-carbon sugar and one of four nitrogenous bases. Although most RNA is single-stranded, it can form complex secondary and tertiary structures. Such structures play essential roles in the regulation of transcription and translation.
Different Types of RNA Have the Same Basic Structure
There are three main types of ribonucleic acid (RNA): messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). All three RNA types consist of a...
01:53RNA Stability
01:32RNA Splicing
02:23RNA Editing